Peptide-drug conjugates as therapeutic modality in drug development 2

Click to launch & play an online audio visual presentation by Dr. Syed Faheem Askari Rizvi on Peptide-drug conjugates as therapeutic modality in drug development 2, part of a collection of multimedia lectures.

Authors

Syed Faheem Askari Rizvi (ORCID: https://orcid.org/0000-0002-8671-9168)

Institutions

Xiamen University (CN)

Publication Details

Journal: The biomedical & life sciences collection.
Published: 2025-06-30
DOI: https://doi.org/10.69645/brsv5347
Primary Topic: Chemical Synthesis and Analysis
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Peptide-drug conjugates as therapeutic modality in drug development 2

Syed Faheem Askari Rizvi

Jun 30, 2025

The biomedical & life sciences collection.

Chemical Synthesis and Analysis

article

Peptide-drug conjugates as therapeutic modality in drug development 2

Syed Faheem Askari Rizvi

June 30, 2025article en

Abstract

The biomedical & life sciences collection.Vol. 2025(6)

Xiamen University (CN)

Openalex Percentile: Top 86%

Chemical Synthesis and Analysis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Peptide-drug conjugates as therapeutic modality in drug development 2 — Syed Faheem Askari Rizvi · The biomedical & life sciences collection. (2025) | TGRS Research Map | TGRS